Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial. - Magnolo, Nina; Soung, Jennifer; Frew, John; Costanzo, Antonio; Ruiz-Santiago, Hiram; Eyerich, Kilian; Llamas-Velasco, Mar; Bukhalo, Michael; Sivamani, Raja K.; Moore, Angela; Wu, Tianshuang; Xie, Jiaheng; et al. (Dermatology & Therapy, 2026)